Bimekizumab

(Synonyms: CDP4940; UCB-4940)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation.

For research use only. We do not sell to patients.

  • Purity: 99.44%
  • CAS No.: 1418205-77-2
  • Molecular Weight:147.24 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Bimekizumab

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00